BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16264954)

  • 1. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 2. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening with a fecal multitarget DNA test.
    Young GP; Worthley DL
    Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
    [No Abstract]   [Full Text] [Related]  

  • 5. Fecal DNA for colorectal-cancer screening.
    Frossard JL; de Peyer R
    N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15800239
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal DNA for colorectal-cancer screening.
    Worthley DL; Cole SR; Young GP
    N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15803528
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
    Brenner DE; Rennert G
    J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
    [No Abstract]   [Full Text] [Related]  

  • 9. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.
    Woolf SH
    N Engl J Med; 2004 Dec; 351(26):2755-8. PubMed ID: 15616212
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 11. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stool DNA: a viable option for colorectal cancer screening.
    Hardison DM; Shuber AP
    Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive testing for colorectal cancer: a review.
    Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
    Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; GalatĂ  G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Future perspectives in screening for colorectal cancer].
    Kronborg O
    Ugeskr Laeger; 2005 Oct; 167(44):4193-4. PubMed ID: 16266579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal screening of colorectal cancer.
    Loganayagam A
    Int J Clin Pract; 2008 Mar; 62(3):454-9. PubMed ID: 17887994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for colorectal cancer: importance of fecal occult blood test].
    De Paula AO
    Acta Gastroenterol Latinoam; 1999; 29(2):79-81. PubMed ID: 10491720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.